• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种通用方法来优化预融合闭合 HIV-1 包膜三聚体的折叠和稳定性。

A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.

机构信息

Janssen Vaccines & Prevention, Archimedesweg 4-6, Leiden 2333, the Netherlands.

Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD 20892, USA.

出版信息

Cell Rep. 2018 Apr 10;23(2):584-595. doi: 10.1016/j.celrep.2018.03.061.

DOI:10.1016/j.celrep.2018.03.061
PMID:29642014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6010203/
Abstract

The heavily glycosylated native-like envelope (Env) trimer of HIV-1 is expected to have low immunogenicity, whereas misfolded forms are often highly immunogenic. High-quality correctly folded Envs may therefore be critical for developing a vaccine that induces broadly neutralizing antibodies. Moreover, the high variability of Env may require immunizations with multiple Envs. Here, we report a universal strategy that provides for correctly folded Env trimers of high quality and yield through a repair-and-stabilize approach. In the repair stage, we utilized a consensus strategy that substituted rare strain-specific residues with more prevalent ones. The stabilization stage involved structure-based design and experimental assessment confirmed by crystallographic feedback. Regions important for the refolding of Env were targeted for stabilization. Notably, the α9-helix and an intersubunit β sheet proved to be critical for trimer stability. Our approach provides a means to produce prefusion-closed Env trimers from diverse HIV-1 strains, a substantial advance for vaccine development.

摘要

HIV-1 高度糖基化的天然样包膜 (Env) 三聚体预计免疫原性较低,而错误折叠的形式通常具有高度免疫原性。因此,高质量正确折叠的 Env 对于开发诱导广泛中和抗体的疫苗可能至关重要。此外,Env 的高度变异性可能需要用多种 Env 进行免疫接种。在这里,我们报告了一种通用策略,通过修复和稳定方法提供高质量和高产量的正确折叠的 Env 三聚体。在修复阶段,我们利用了一种共识策略,用更常见的取代稀有株特异性残基。稳定阶段涉及基于结构的设计,实验评估通过晶体学反馈得到证实。针对 Env 重折叠的重要区域进行了稳定化处理。值得注意的是,α9 螺旋和亚基间 β 片层被证明对三聚体稳定性至关重要。我们的方法提供了一种从多种 HIV-1 株生产预融合封闭 Env 三聚体的手段,这是疫苗开发的重大进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/14a8fc6dee70/nihms961955f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/9aaec0aeb2d0/nihms961955f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/3e0ea9d6bc36/nihms961955f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/717349f8f2ad/nihms961955f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/c687e42f151a/nihms961955f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/84387dd48de8/nihms961955f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/14a8fc6dee70/nihms961955f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/9aaec0aeb2d0/nihms961955f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/3e0ea9d6bc36/nihms961955f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/717349f8f2ad/nihms961955f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/c687e42f151a/nihms961955f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/84387dd48de8/nihms961955f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa3e/6010203/14a8fc6dee70/nihms961955f6.jpg

相似文献

1
A Universal Approach to Optimize the Folding and Stability of Prefusion-Closed HIV-1 Envelope Trimers.一种通用方法来优化预融合闭合 HIV-1 包膜三聚体的折叠和稳定性。
Cell Rep. 2018 Apr 10;23(2):584-595. doi: 10.1016/j.celrep.2018.03.061.
2
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.基于结构设计具有降低CD4亲和力和增强免疫原性的可溶性前融合封闭型HIV-1包膜三聚体
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02268-16. Print 2017 May 15.
3
Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.预融合HIV-1包膜三聚体与四级结构特异性抗体复合物的免疫原性
J Virol. 2015 Dec 30;90(6):2740-55. doi: 10.1128/JVI.02380-15.
4
Structure-Guided Redesign Increases the Propensity of HIV Env To Generate Highly Stable Soluble Trimers.基于结构的重新设计提高了HIV包膜蛋白产生高度稳定可溶性三聚体的倾向。
J Virol. 2015 Dec 30;90(6):2806-17. doi: 10.1128/JVI.02652-15.
5
Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.开发一种 3Mut-Apex-Stabilized 包膜三聚体,当用于增强融合肽指导的疫苗诱导的反应时,可扩大 HIV-1 中和广度。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00074-20.
6
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes.通过靶向序列改变提高可溶性、重组天然样HIV-1包膜糖蛋白三聚体的表达和纯化
J Virol. 2017 May 26;91(12). doi: 10.1128/JVI.00264-17. Print 2017 Jun 15.
7
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.可溶性融合前封闭 DS-SOSIP.664-Env 三聚体的多种 HIV-1 株系。
Cell Rep. 2017 Dec 5;21(10):2992-3002. doi: 10.1016/j.celrep.2017.11.016.
8
Automated Design by Structure-Based Stabilization and Consensus Repair to Achieve Prefusion-Closed Envelope Trimers in a Wide Variety of HIV Strains.基于结构的稳定化和共识修复的自动化设计,以实现在多种 HIV 株中达到预融合封闭的三聚体。
Cell Rep. 2020 Nov 24;33(8):108432. doi: 10.1016/j.celrep.2020.108432.
9
Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein.一种高效裂解的印度HIV-1 C亚型包膜糖蛋白的可溶性、天然三聚体形式的稳定化。
J Biol Chem. 2017 May 19;292(20):8236-8243. doi: 10.1074/jbc.M117.776419. Epub 2017 Mar 10.
10
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers.对可溶性、重组天然样HIV-1包膜糖蛋白三聚体设计与纯化的影响
J Virol. 2015 Dec;89(23):12189-210. doi: 10.1128/JVI.01768-15. Epub 2015 Aug 26.

引用本文的文献

1
A nanobody specific to prefusion glycoprotein B neutralizes HSV-1 and HSV-2.一种针对融合前糖蛋白B的纳米抗体可中和单纯疱疹病毒1型和单纯疱疹病毒2型。
Nature. 2025 Sep 3. doi: 10.1038/s41586-025-09438-5.
2
Rapid acquisition of HIV-1 neutralization breadth in a rhesus V2 apex germline antibody mouse model after a single bolus immunization.在恒河猴V2尖峰种系抗体小鼠模型中,单次大剂量免疫后HIV-1中和广度的快速获得。
bioRxiv. 2025 Jun 17:2025.06.12.659380. doi: 10.1101/2025.06.12.659380.
3
Addressing SARS-CoV-2 evolution: neutralization of emerging variants of concern by the AVX/COVID-12 'Patria' vaccine based on HexaPro-S ancestral Wuhan spike or its updated BA.2.75.2 version.

本文引用的文献

1
Soluble Prefusion Closed DS-SOSIP.664-Env Trimers of Diverse HIV-1 Strains.可溶性融合前封闭 DS-SOSIP.664-Env 三聚体的多种 HIV-1 株系。
Cell Rep. 2017 Dec 5;21(10):2992-3002. doi: 10.1016/j.celrep.2017.11.016.
2
Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding.基于结构的设计使 HIV-1 包膜三聚体更接近天然状态,从而使非中和表位失活,并消除 CD4 结合。
Nat Commun. 2017 Nov 21;8(1):1655. doi: 10.1038/s41467-017-01549-6.
3
High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers.
应对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的进化:基于六聚体原武汉株刺突蛋白或其更新的BA.2.75.2版本的AVX/COVID-12“Patria”疫苗对新出现的变异株的中和作用。
Front Immunol. 2025 May 19;16:1565934. doi: 10.3389/fimmu.2025.1565934. eCollection 2025.
4
Progress and Challenges in HIV-1 Vaccine Research: A Comprehensive Overview.人类免疫缺陷病毒1型疫苗研究的进展与挑战:全面综述
Vaccines (Basel). 2025 Jan 31;13(2):148. doi: 10.3390/vaccines13020148.
5
The Design and Immunogenicity of an HIV-1 Clade C Pediatric Envelope Glycoprotein Stabilized by Multiple Platforms.通过多种平台稳定的HIV-1 C亚型儿科包膜糖蛋白的设计与免疫原性
Vaccines (Basel). 2025 Jan 22;13(2):110. doi: 10.3390/vaccines13020110.
6
Neutralizing antibodies elicited in macaques recognize V3 residues on altered conformations of HIV-1 Env trimer.猕猴体内产生的中和抗体可识别HIV-1包膜三聚体构象改变时的V3残基。
NPJ Vaccines. 2024 Dec 5;9(1):240. doi: 10.1038/s41541-024-01038-0.
7
Potent and broad HIV-1 neutralization in fusion peptide-primed SHIV-infected macaques.在融合肽引发的感染SHIV的猕猴中实现强效且广泛的HIV-1中和作用。
Cell. 2024 Dec 12;187(25):7214-7231.e23. doi: 10.1016/j.cell.2024.10.003. Epub 2024 Oct 28.
8
Enhanced Expression of the Gene of Vaccinia Virus by the tPA Signal Sequence Inserted in a Fowlpox-Based Recombinant Vaccine.通过插入基于鸡痘的重组疫苗中的组织型纤溶酶原激活剂(tPA)信号序列增强痘苗病毒基因的表达。
Vaccines (Basel). 2024 Sep 29;12(10):1115. doi: 10.3390/vaccines12101115.
9
Engineering a cleaved, prefusion-stabilized influenza B virus hemagglutinin by identification and locking of all six pH switches.通过识别和锁定所有六个pH开关构建一种裂解的、预融合稳定的乙型流感病毒血凝素
PNAS Nexus. 2024 Oct 11;3(10):pgae462. doi: 10.1093/pnasnexus/pgae462. eCollection 2024 Oct.
10
Structures of the Foamy virus fusion protein reveal an unexpected link with the F protein of paramyxo- and pneumoviruses.泡沫病毒融合蛋白的结构揭示了与副粘病毒和肺病毒 F 蛋白的意外联系。
Sci Adv. 2024 Oct 11;10(41):eado7035. doi: 10.1126/sciadv.ado7035.
高通量蛋白质工程改善了可溶性HIV-1包膜糖蛋白SOSIP三聚体的抗原性和稳定性。
J Virol. 2017 Oct 27;91(22). doi: 10.1128/JVI.00862-17. Print 2017 Nov 15.
4
Improving the Immunogenicity of Native-like HIV-1 Envelope Trimers by Hyperstabilization.通过超稳定化提高天然样 HIV-1 包膜三聚体的免疫原性。
Cell Rep. 2017 Aug 22;20(8):1805-1817. doi: 10.1016/j.celrep.2017.07.077.
5
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen.一种合理设计的预融合 MERS-CoV 刺突抗原的免疫原性和结构。
Proc Natl Acad Sci U S A. 2017 Aug 29;114(35):E7348-E7357. doi: 10.1073/pnas.1707304114. Epub 2017 Aug 14.
6
Open and closed structures reveal allostery and pliability in the HIV-1 envelope spike.开放和封闭结构揭示了HIV-1包膜刺突中的变构和柔韧性。
Nature. 2017 Jul 20;547(7663):360-363. doi: 10.1038/nature23010. Epub 2017 Jul 12.
7
Structural basis for antibody-mediated neutralization of Lassa virus.抗体介导的拉沙病毒中和作用的结构基础。
Science. 2017 Jun 2;356(6341):923-928. doi: 10.1126/science.aam7260.
8
Glycine Substitution at Helix-to-Coil Transitions Facilitates the Structural Determination of a Stabilized Subtype C HIV Envelope Glycoprotein.在螺旋-卷曲转变处进行甘氨酸取代有助于稳定的C亚型HIV包膜糖蛋白的结构测定。
Immunity. 2017 May 16;46(5):792-803.e3. doi: 10.1016/j.immuni.2017.04.014.
9
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes.通过靶向序列改变提高可溶性、重组天然样HIV-1包膜糖蛋白三聚体的表达和纯化
J Virol. 2017 May 26;91(12). doi: 10.1128/JVI.00264-17. Print 2017 Jun 15.
10
Structure-Based Design of a Soluble Prefusion-Closed HIV-1 Env Trimer with Reduced CD4 Affinity and Improved Immunogenicity.基于结构设计具有降低CD4亲和力和增强免疫原性的可溶性前融合封闭型HIV-1包膜三聚体
J Virol. 2017 Apr 28;91(10). doi: 10.1128/JVI.02268-16. Print 2017 May 15.